• Non ci sono risultati.

Scarica il programma in formato PDF

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma in formato PDF"

Copied!
2
0
0

Testo completo

(1)

Under The AUspices Of

2

nd

RIMOG

new and emerging Therapeutic Options in Geriatric Oncology

Florence, June 30 - July 1, 2016

Aula Magna NIC - AOUC Careggi

Honorary President: Guido Francini

Presidents: Enrico Mini and Silverio Tomao

Faculty

UnresTricTed GrAnT BY

Honorary President: Guido Francini

Presidents: Enrico Mini and Silverio Tomao Meeting Venue

Aula Magna NIC - AOUC Careggi - Largo Brambilla, 3 - florence, italy General Information

www.rimog.net

Meeting Secretariat and CME Provider

Mi&T srl - Viale carducci, 50 - 40125 Bologna

Tel. 051 220427 - 335 5918811 - [email protected] - www.mitcongressi.it CME We required credits cMe for the following professionals: Oncologist, radiotherapist Geriatrician, surgeon, Biologist, pathologist and Geneticist.

subscription is free after registration online from the website www.mitcongressi.it section: 2nd riMOG new and emerging Therapeutic Options in Geriatric Oncology

siLVer pLATinUM

Gianni Amunni Ludovico Balducci Jonathan A. Ledermann fortunato ciardiello

Scientific Committee

stuart M. Lichtman Teresita Mazzei carlo croce Jean-pierre droz

daniel J. sargent Adriano Tocchi celestia s. higano Joleen M. hubbard

Scientific Coordinators

Vincenzo Bianco edoardo francini federica Tomao inTernATiOnAL

J.M. Broto seville (spain) c. croce columbus (UsA) J.p. droz Lyon (france) J.p. dutcher new York (UsA) K. fizazi paris (france) r.J. Gralla new York (UsA) V. Grünwald hannover (Germany) c.s. higano seattle (UsA)

J.M. hubbard rochester (UsA) M.h. hussain Ann Arbor (UsA) f. Joly caen (france) e. Jonasch houston (UsA)

p.W. Kantoff new York (UsA) J.A. Ledermann London (UK) s.M. Lichtman new York (UsA)

s. Loibl neu-isenburg (Germany) s.G. Mohile rochester (UsA)

T.s.K. Mok hong Kong (china) e.A. perez rochester (UsA) M. reck hamburg (Germany) M.T. seymour London (UK)

f.A. shepherd Toronto (canada) c. Twelves Leeds (UK)

nATiOnAL

M. Aglietta Torino A. Antonuzzo pisa p. Benedetti panici roma c. Bengala Grosseto f. Boccardo Genova s. Bracarda Arezzo f. cappuzzo ravenna p. casali Milano f. ciardiello napoli f. cognetti roma A.p. dei Tos Treviso f. di costanzo firenze G.e. Grignani Torino

A. Lapini firenze

L. Livi firenze

M. Mannocci firenze p. Marchetti roma e. Mini firenze

L. Muzii roma

i. petrini pisa M. s. pino firenze f. puglisi Udine V. Quagliuolo Milano M. r. raspollini firenze A. riccardi pavia d. santini roma G. scambia roma

s. Tomao roma

G. Tortora Verona B. Vincenzi roma

BrOnze GOLd

(2)

June 30, 2016

July 1, 2016

08:00 Registration

08:30 Opening - G. Francini

08:40 Welcome from Tuscany’s Health Commissioner - S. Saccardi 08:50 Welcome from ITT - G. Amunni

SESSION I ManageMent of the elderly with cancer

Co-chairs: M. Aglietta, S.M. Lichtman

09:00 The scope of palliative care - S.M. Lichtman

09:20 Developments in the prevention and management of CINV - R.J. Gralla 09:40 Quality of life and pain - J.P. Droz

10:00 Panel discussion - A. Antonuzzo, M. Mannocci, M.S. Pino 10:30 Coffee break

SESSION II Breast cancer

Co-chairs: C. Croce, E.A. Perez

11:00 Do we need special trials? - C. Twelves 11:20 Role of immunotherapy - E.A. Perez

11:40 Neoadjuvant and postneoadjuvant approaches - S. Loibl 12:00 Panel discussion - P. Marchetti, F. Puglisi, A. Riccardi

SESSION III lung cancer

Co-chairs: F. Ciardiello, F.A. Shepherd

12:30 SCLC: updates and state of the art - F.A. Shepherd

12:50 NSCLC: Treatment of EGFR mutation and ALK positive patients - M. Reck 13:10 A new perspective: T-790M inhibition - T.S.K. Mok

13:30 Panel discussion (Role of immunotherapy) - F. Cappuzzo, F. Cognetti, I. Petrini 14:00 Lunch

SESSION IV ovarian cancer

Co-chairs: P. Benedetti Panici, J. Ledermann

15:00 Primary surgery or neoadjuvant chemotherapy? - G. Scambia 15:20 What are the optimal medical treatments? - F. Joly

15:40 Panel discussion - L. Muzii, S. Tomao

SESSION V colorectal cancer

Co-chairs: J.M. Hubbard, S.G. Mohile 16:00 Adjuvant therapy - J.M. Hubbard

16:20 Treatment of patients with metastatic disease - M.T. Seymour 16:40 Incorporating the geriatric assessment into the management

of older patients - S.G. Mohile

17:00 Panel discussion - F. Di Costanzo, E. Mini, G. Tortora

SESSION VI Prostate cancer

Co-chairs: C.S. Higano, P.W. Kantoff

08:30 Update on treatment options for metastatic disease - M.H. Hussain 08:50 Mechanisms of resistance to treatment - P.W. Kantoff

09:10 Personalizing treatments: what is the status? - K. Fizazi 09:30 Panel discussion - F. Boccardo, A. Lapini, M.R. Raspollini

SESSION VII Kidney cancer

Co-chairs: J.P. Dutcher, E. Jonasch

09:50 Treatment of RCC - new tools on the horizon - V. Grünwald 10:10 Panel discussion - C. Bengala, S. Bracarda, D. Santini 10:40 Coffee break

SESSION VIII soft tissue sarcoMa

Co-chairs: P. Casali, V. Quagliuolo

11:00 Medical treatment in elderly patients - J.M. Broto 11:20 Beyond chemotherapy in elderly patients - L. Livi

11:40 Panel discussion - A.P. Dei Tos, G.E. Grignani, B. Vincenzi

highlights and conclusions

Co-chairs: P.W. Kantoff, E.A. Perez 12:10 Breast cancer - C. Twelves 12:20 Lung cancer - F. Ciardiello 12:30 Ovarian cancer - J.A. Ledermann 12:40 Colorectal cancer - J.M. Hubbard 12:50 Prostate cancer - C.S. Higano 13:00 Kidney cancer - J.P. Dutcher 13:10 Soft Tissue Sarcoma - P. Casali

13:20 Management of the elderly with cancer - S.M. Lichtman 13:30 Closing - G. Francini

13:40 Lunch

Riferimenti

Documenti correlati

“IO FORUM 2021 Emerging Approaches for Immunotherapy in Oncology - Regional Webinar PIEMONTE” è il secondo appuntamento della roadmap.. L’evento intende focalizzare e comunicare

“IO FORUM 2021 Emerging Approaches for Immunotherapy in Oncology - Regional Webinar LAZIO” è il primo appuntamento della roadmap in cui discutere le prospettive e le

Enrico Vasile 15.00 Locally advanced unresectable disease: treatment options. Kalliopi Andrikou 15.20 First and second line chemotherapy: a

5,15 - 7,30 pm Plenary Session 3: Old and emerging biomarkers for thrombosis and disease progression in cancer.. Chairs: B Brenner (Israel); S

Motivation letter describing your intended project in the field of Geriatric Oncology within your professional activity. Short CV (max. 2 pages) describing recent clinical experience

MULTIPLE MYELOMA 2016 University Magna Græcia, Catanzaro (Italy).. 30 th June - 2 nd

Chairmen: Giorgio Mustacchi - Christopher Twelves HER-2 + breast cancer. Matching different therapeutic choices (Christopher Twelves) Novel approaches in endocrine sensitive

Christian Rolfo: Clinical Trial Management Program Oncology Department University Hospital Antwerp UZA, Edegem, Belgium Luca Toschi: Humanitas Cancer Center, IRCCS U.O. di Oncologia